8-(2-羟基-3-甲氧苯基)-7-甲基-7,8-二氢-6H-[1,3]二噁唑并[4,5-g]色烯-6-醇 | 117211-16-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 新黄酮类化合物
• 中文名称: 8-(2-羟基-3-甲氧苯基)-7-甲基-7,8-二氢-6H-[1,3]二噁唑并[4,5-g]色烯-6-醇
• 英文名称: 7,8-Dihydro-8-(2-hydroxy-3-methoxyphenyl)-7-methyl-6H-1,3-dioxolo(4,5-g)(1)benzopyran-6-ol
• 英文别名: 8-(2-hydroxy-3-methoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-ol
• CAS: 117211-16-2
• 化学式: C₁₈H₁₈O₆
• 分子量: 330.3
• InChiKey: DYDGSGOMYSJIRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  77.4
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Chemical entities that kill senescent cells for use in treating age-related disease
  申请人：Unity Biotechnology, Inc.

  公开号：US10195213B2

  公开（公告）日：2019-02-05

  Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.

  本文公开的化合物可有效治疗与衰老有关的各种疾病状态。所公开的化合物可用于消除衰老细胞以治疗疾病。化合物的给药方式包括单次给药和循环给药。
• COMPOUNDS AND THERAPEUTIC USES
  申请人：Unity Biotechnology, Inc.

  公开号：US20170281649A1

  公开（公告）日：2017-10-05

  Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.